Welcome to the
Sugarbaker Oncology Associates Home Page

 

 

Paul H. Sugarbaker, MD, FACS, FRCS

 

 



We are the Center for Surgical Oncology at the Washington Cancer Institute, Washington Hospital Center, in Washington, D.C. We specialize in the surgical treatment of cancers that arise in the gastrointestinal tract (appendix cancer, colon cancer, and rectal cancer); and other areas of the abdomen and pelvis.

Our advanced services include specialty treatment programs for pseudomyxoma peritonei, peritoneal carcinomatosis (cancers that have spread to the intraabdominal surfaces), as well as primary peritoneal surface malignancies such as peritoneal mesothelioma.



 

 

UPCOMING EVENTS:

8th International World Congress on Peritoneal Surface Malignancy

Berlin, Germany

October 31 – November 2, 2012

www.peritonealconference2012.com

 

 

New and recent medical articles/journals authored or co-authored by Dr. Sugarbaker:

 

  1. Sugarbaker PH. Parietal peritonectomy. Ann Surg Oncol. 2012 Apr;19(4):1250.  Epub 2012 Feb 10. PubMed PMID: 22322950.

  2. Sugarbaker PH. Second-look surgery for colorectal cancer: revised selection factors and new treatment options for greater success. Int J Surg Oncol. 2011;2011:915078. Epub 2010 Dec 5. PubMed PMID: 22312530; PubMed Central PMCID: PMC3263683.

  3. Casado-Adam A, Alderman R, Stuart OA, Chang D, Sugarbaker PH. Gastrointestinal complications in 147 consecutive patients with peritoneal surface malignancy treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy. Int J Surg Oncol. 2011;2011:468698. Epub 2011 Oct 16. PubMed PMID: 22312509; PubMed Central PMCID: PMC3263671.

  4. Van der Speeten K, Stuart OA, Mahteme H, Sugarbaker PH. Pharmacokinetic study of perioperative intravenous Ifosfamide. Int J Surg Oncol. 2011;2011:185092. Epub 2011 Sep 21. PubMed PMID: 22312496; PubMed Central PMCID: PMC3263669.

  5. Sugarbaker PH, Stuart OA, Bijelic L. Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: rationale and report of early data. Int J Surg Oncol. 2011;2011:161862. Epub 2011 Dec 12. PubMed PMID: 22312494; PubMed Central PMCID: PMC3263652.

  6. Cao C, Yan TD, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH; Peritoneal Surface Malignancy Group. Importance of gender in diffuse malignant peritoneal mesothelioma. Ann Oncol. 2011 Nov 4. [Epub ahead of print] PubMed PMID: 22056853.

  7. Sugarbaker PH, Van der Speeten K, Anthony Stuart O, Chang D. Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis. Eur J Surg Oncol. 2011 Aug;37(8):719-26. Epub 2011 May 31. PubMed PMID: 21621952.

  8. Yan TD, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH; Peritoneal Surface Oncology Group. A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*. Cancer. 2011 May 1;117(9):1855-63. doi: 10.1002/cncr.25640. Epub 2010 Nov 18. PubMed PMID: 21509762.

  9. Ortega-Deballon P, Glehen O, Levine E, Piso P, Sugarbaker PH, Hayes-Jordan A, Facy A, Bakrin N, Rat P. Childbearing after hyperthermic intraperitoneal chemotherapy: results from an International survey. Ann Surg Oncol. 2011 Aug;18(8):2297-301. Epub 2011 Feb 11. PubMed PMID: 21311981.

  10. Sugarbaker PH. Twenty-three years of progress in the management of a rare disease. Dis Colon Rectum. 2011 Mar;54(3):265-6. PubMed PMID: 21304294.


 

 

 

Check out our web publications!

Management of Peritoneal Surface Malignancy Using
Intraperitoneal Chemotherapy and Cytoreductive Surgery:
A Manual for Physicians and Nurses

Atlas of Appendix Cancer and Pseudomyxoma Peritonei

Management of Peritoneal Surface Malignancy:
Appendix Cancer and Pseudomyxoma Peritonei, Colon Cancer, and Primary Peritoneal Malignancy

Hyperthermic Intraoperative Intraperitoneal Chemotherapy Tutorial

Protocol for the Implementation of Treatment of Patients with Peritoneal Surface Malignancy with Hyperthermic Intraoperative Intraperitoneal Chemotherapy and Normothermic Early Postoperative Intraperitoneal Chemotherapy

Technical Handbook for the Integration of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy into the Surgical Management of Gastrointestinal and Gynecologic Malignancy



We are pleased to introduce our list of international colleagues.




Introduction to SOAIntroduction to SOA

Introduction to SOAQuick Tour of Our Web Site

Introduction to SOAQuick Tour of Washington Hospital Center

Introduction to SOAResources for Patients and Families

Introduction to SOAResources for Medical Professionals

Introduction to SOAFARGO

Introduction to SOAYour Surgery & Hospitalization: What to Expect



Please contact us at:

Sugarbaker Oncology Associates
Washington Hospital Center
106 Irving St., NW, Suite 3900
Washington, D.C. 20010

Phone 202-877-3908
Fax 202-877-8602

You are visitor number
Hit Counter

Copyright 1996
Sugarbaker Oncology Associates
Washington Hospital Center
106 Irving St., NW, Suite 3900N
Washington, D.C. 20010

All Rights Reserved


Last Revised 03/22/2012